ICD-10-CM Billable Code

A23.9

Brucellosis, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Brucellosis is an infectious disease caused by bacteria from the genus Brucella. When the specific type or source of the infection isn’t identified, it is classified as 'unspecified' and coded as A23.9 in the ICD-10 system. This disease primarily affects animals but can be transmitted to humans, leading to various symptoms that can range from mild to severe. Understanding brucellosis and its implications is important for those at risk or experiencing symptoms associated with the infection.

Causes & Symptoms

Clinical Causes: Consuming unpasteurized milk or dairy products from infected animals. Handling or visiting infected animals, especially livestock like cattle, goats, or sheep. Inhalation of airborne bacteria in environments where infected animals or contaminated materials are present. Direct contact with infected animal tissues or fluids, such as during farming or slaughtering activities.

Key Symptoms: Fever, often recurring or fluctuating Sweats, particularly at night Fatigue and weakness Muscle and joint pain Loss of appetite and weight loss Headaches Swollen and tender lymph nodes Malaise or general discomfort In some cases, hepatomegaly (enlarged liver) or splenomegaly (enlarged spleen)

Diagnostic & Treatment

Diagnosis Path: The diagnosis of brucellosis involves a combination of clinical evaluation and laboratory testing. Medical professionals may perform blood tests to detect antibodies against Brucella bacteria, such as the Rose Bengal test or ELISA. Blood cultures can also be used to identify the bacteria directly, although this test can take longer. Imaging studies might be required if complications like abscesses develop, especially in the liver or other organs.

Treatment Protocols: Management of brucellosis typically involves a course of antibiotics to eliminate the bacteria. Treatment regimens often include combinations like doxycycline with rifampin or streptomycin. The duration of therapy can vary from several weeks to months, depending on the severity and extent of the infection. In cases involving complication or relapse, prolonged treatment and monitoring may be necessary. Supportive care, such as rest and hydration, can help alleviate symptoms during recovery.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is A23.9 a billable ICD-10 code?
Yes, A23.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report A23.9?
Clinical documentation must specify the nature of Brucellosis, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes